These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ; Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092 [TBL] [Abstract][Full Text] [Related]
6. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758 [TBL] [Abstract][Full Text] [Related]
7. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan. Lin CC; Liu TC; Kuo CF; Liu CP; Lee CM J Microbiol Immunol Infect; 2010 Aug; 43(4):323-31. PubMed ID: 20688293 [TBL] [Abstract][Full Text] [Related]
8. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria. Tumbarello M; De Pascale G; Trecarichi EM; De Martino S; Bello G; Maviglia R; Spanu T; Antonelli M Chest; 2013 Dec; 144(6):1768-1775. PubMed ID: 23989805 [TBL] [Abstract][Full Text] [Related]
9. Comparison of two therapeutic approaches for the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter: a randomized clinical trial study. Khorvash F; Yaghoubi S; Farsaei S; Ataei B; Hakamifard A; Mohajeri F; Gudarzi M J Immunoassay Immunochem; 2020; 41(1):97-105. PubMed ID: 31777299 [TBL] [Abstract][Full Text] [Related]
10. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study. Kofteridis DP; Alexopoulou C; Valachis A; Maraki S; Dimopoulou D; Georgopoulos D; Samonis G Clin Infect Dis; 2010 Dec; 51(11):1238-44. PubMed ID: 20973727 [TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review. Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083 [TBL] [Abstract][Full Text] [Related]
12. Use of aerosolized aminoglycosides in the treatment of Gram-negative ventilator-associated pneumonia. Mohr AM; Sifri ZC; Horng HS; Sadek R; Savetamal A; Hauser CJ; Livingston DH Surg Infect (Larchmt); 2007 Jun; 8(3):349-57. PubMed ID: 17635058 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study. Kallel H; Hergafi L; Bahloul M; Hakim A; Dammak H; Chelly H; Hamida CB; Chaari A; Rekik N; Bouaziz M Intensive Care Med; 2007 Jul; 33(7):1162-1167. PubMed ID: 17530220 [TBL] [Abstract][Full Text] [Related]
14. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii]. Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381 [TBL] [Abstract][Full Text] [Related]
15. Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial. Liu C; Zhang YT; Peng ZY; Zhou Q; Hu B; Zhou H; Li JG Chin Med J (Engl); 2017 May; 130(10):1196-1201. PubMed ID: 28485320 [TBL] [Abstract][Full Text] [Related]
16. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Palmer LB; Smaldone GC; Chen JJ; Baram D; Duan T; Monteforte M; Varela M; Tempone AK; O'Riordan T; Daroowalla F; Richman P Crit Care Med; 2008 Jul; 36(7):2008-13. PubMed ID: 18552684 [TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia. Nicasio AM; Eagye KJ; Nicolau DP; Shore E; Palter M; Pepe J; Kuti JL J Crit Care; 2010 Mar; 25(1):69-77. PubMed ID: 19427167 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology study of Bramitob, a tobramycin solution for nebulization, in comparison with Tobi. Poli G; Acerbi D; Pennini R; Soliani Raschini A; Corrado ME; Eichler HG; Eichler I Paediatr Drugs; 2007; 9 Suppl 1():3-9. PubMed ID: 17536870 [TBL] [Abstract][Full Text] [Related]
19. Use of nebulized antimicrobial agents in burned and mechanically ventilated patients with persistent Acinetobacter baumannii, Pseudomonas aeruginosa, or Enterobacteriacea. Ackerman BH; Reigart CL; Stair-Buchmann M; Haith LR; Patton ML; Guilday RE Burns; 2013 Aug; 39(5):885-91. PubMed ID: 23195712 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study. Chastre J; Wunderink R; Prokocimer P; Lee M; Kaniga K; Friedland I Crit Care Med; 2008 Apr; 36(4):1089-96. PubMed ID: 18379232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]